Burke P - Search Results

1

Oncology stewardship in acute myeloid leukemia.

Ochs MA, Marini BL, Perissinotti AJ, Foucar CE, Pettit K, Burke P, Bixby DL, Benitez LL. Ochs MA, et al. Among authors: burke p. Ann Hematol. 2022 Aug;101(8):1627-1644. doi: 10.1007/s00277-022-04872-1. Epub 2022 May 26. Ann Hematol. 2022. PMID: 35618780 Review.

2

Minimizing waste during preparation of blinatumomab infusions.

Marini BL, Wechter AR, Burke PW, Bixby D, Perissinotti AJ. Marini BL, et al. Am J Health Syst Pharm. 2016 Jan 15;73(2):19-20. doi: 10.2146/ajhp150420. Am J Health Syst Pharm. 2016. PMID: 26721530 No abstract available.

3

Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome.

Marini BL, Sun Y, Burke PW, Perissinotti AJ. Marini BL, et al. J Oncol Pharm Pract. 2018 Jan;24(1):67-73. doi: 10.1177/1078155216676633. Epub 2016 Oct 31. J Oncol Pharm Pract. 2018. PMID: 27799606

4

Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.

Kandarpa M, Wu YM, Robinson D, Burke PW, Chinnaiyan AM, Talpaz M. Kandarpa M, et al. Am J Hematol. 2017 Jun;92(6):555-561. doi: 10.1002/ajh.24728. Epub 2017 May 2. Am J Hematol. 2017. PMID: 28335073 Free article.

5

Catalyzing improvements in ALL therapy with asparaginase.

Marini BL, Perissinotti AJ, Bixby DL, Brown J, Burke PW. Marini BL, et al. Blood Rev. 2017 Sep;31(5):328-338. doi: 10.1016/j.blre.2017.06.002. Epub 2017 Jul 5. Blood Rev. 2017. PMID: 28697948 Review.

6

PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia ^†.

Rausch CR, Marini BL, Benitez LL, Elias A, Burke PW, Bixby D, Perissinotti AJ. Rausch CR, et al. Leuk Lymphoma. 2018 Mar;59(3):617-624. doi: 10.1080/10428194.2017.1349902. Epub 2017 Jul 18. Leuk Lymphoma. 2018. PMID: 28718698

7

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.

Vulaj V, Perissinotti AJ, Uebel JR, Nachar VR, Scappaticci GB, Crouch A, Bixby DL, Burke PW, Maillard I, Talpaz M, Marini BL. Vulaj V, et al. Leuk Res. 2018 Jul;70:91-96. doi: 10.1016/j.leukres.2018.05.011. Epub 2018 Jun 1. Leuk Res. 2018. PMID: 29908418

8

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.

Cheung E, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Benitez LL, Brown J, Scappaticci GB, Marini BL. Cheung E, et al. Ann Hematol. 2019 Mar;98(3):541-559. doi: 10.1007/s00277-019-03606-0. Epub 2019 Jan 21. Ann Hematol. 2019. PMID: 30666431 Review.

9

A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage.

Marini BL, Brown J, Benitez L, Walling E, Hutchinson RJ, Mody R, Jasty Rao R, Slagle L, Bishop L, Pettit K, Bixby DL, Burke PW, Perissinotti AJ. Marini BL, et al. Leuk Lymphoma. 2019 Dec;60(12):2854-2868. doi: 10.1080/10428194.2019.1608530. Epub 2019 May 17. Leuk Lymphoma. 2019. PMID: 31099289

10

Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Marini BL, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Benitez LL. Marini BL, et al. Cancer. 2019 Nov 1;125(21):3890-3891. doi: 10.1002/cncr.32381. Epub 2019 Jul 10. Cancer. 2019. PMID: 31291001 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

990 results

Search Page